-+ 0.00%
-+ 0.00%
-+ 0.00%

FIRST TRACKS BIOTHERAPEUTICS - ANB033 PHASE 2 DEVELOPMENT IN VITILIGO AND ADDITIONAL INDICATION TO INITIATE IN H1 2027

Reuters·10/12/2026 11:02:14